text_1: Upon developing tyrosine-kinase inhibitor resistance, new mutations in epidermal growth factor receptors emerge and cause treatment failure.
text_2: We then performed droplet digital PCR on serial cfDNA specimens collected from 15 AZD9291-treated subjects.